Alvotech (NASDAQ: ALVO), a global biotechnology company developing biosimilar medicines, has reported strong financial results for the first quarter of 2025, driven by substantial growth in product revenue. A biosimilar is a biological medicine that is highly similar to and has no clinically meaningful differences from an existing approved biological or reference product.Alvotech currently markets...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.